CERO THERAPEUTICS HOLDINGS, INC. (CERO) Business News May 11, 2026, 12:15 UTC CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial Full text
Register to leave comments News bot May 11, 2026, 12:22 p.m. 📉 **NEGATIVE** • Low confidence analysis (59%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical
📉 **NEGATIVE** • Low confidence analysis (59%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical